99 related articles for article (PubMed ID: 23160017)
1. [New oral anticoagulants: recommendations, precautions and perspectives for use].
Di Minno G; Russolillo A; Ventre I; Di Minno A; Prisco D
G Ital Cardiol (Rome); 2012 Nov; 13(11 Suppl 1):28S-37S. PubMed ID: 23160017
[TBL] [Abstract][Full Text] [Related]
2. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
3. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
4. Current state of knowledge on oral anticoagulant reversal using procoagulant factors.
Nitzki-George D; Wozniak I; Caprini JA
Ann Pharmacother; 2013 Jun; 47(6):841-55. PubMed ID: 23695644
[TBL] [Abstract][Full Text] [Related]
5. Development and clinical applications of novel oral anticoagulants. Part I. Clinically approved drugs.
Ahrens I; Peter K; Lip GY; Bode C
Discov Med; 2012 Jun; 13(73):433-43. PubMed ID: 22742649
[TBL] [Abstract][Full Text] [Related]
6. Novel anticoagulants for non-valvular atrial fibrillation.
Xu B; Whitbourn R
Heart Lung Circ; 2012 Aug; 21(8):463-7. PubMed ID: 22542860
[TBL] [Abstract][Full Text] [Related]
7. New and emerging anticoagulant therapy for atrial fibrillation and acute coronary syndrome.
Davis EM; Packard KA; Knezevich JT; Campbell JA
Pharmacotherapy; 2011 Oct; 31(10):975-1016. PubMed ID: 21950643
[TBL] [Abstract][Full Text] [Related]
8. Improving the use of direct oral anticoagulants in atrial fibrillation.
Di Minno G; Russolillo A; Gambacorta C; Di Minno A; Prisco D
Eur J Intern Med; 2013 Jun; 24(4):288-94. PubMed ID: 23579170
[TBL] [Abstract][Full Text] [Related]
9. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
Harenberg J; Marx S; Diener HC; Lip GY; Marder VJ; Wehling M; Weiss C
Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
[TBL] [Abstract][Full Text] [Related]
10. The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism.
Mavrakanas T; Bounameaux H
Pharmacol Ther; 2011 Apr; 130(1):46-58. PubMed ID: 21185864
[TBL] [Abstract][Full Text] [Related]
11. Old and new anticoagulant drugs: a minireview.
Mannucci PM; Franchini M
Ann Med; 2011 Mar; 43(2):116-23. PubMed ID: 21254900
[TBL] [Abstract][Full Text] [Related]
12. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
13. Rivaroxaban and atrial fibrillation: continue to use warfarin or in some cases, dabigatran.
Prescrire Int; 2012 Nov; 21(132):257-60. PubMed ID: 23210252
[TBL] [Abstract][Full Text] [Related]
14. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Dumont B; Faille D; Ajzenberg N
Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
[TBL] [Abstract][Full Text] [Related]
15. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.
Martí-Fàbregas J; Mateo J
Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840
[TBL] [Abstract][Full Text] [Related]
16. [Novel oral anticoagulants and their use in the perioperative setting].
Schellong SM; Haas S
Anasthesiol Intensivmed Notfallmed Schmerzther; 2012 Apr; 47(4):266-72; quiz 273. PubMed ID: 22504623
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulant management in the cardiovascular setting.
Verheugt FW
Fundam Clin Pharmacol; 2012 Feb; 26(1):11-5. PubMed ID: 21831129
[TBL] [Abstract][Full Text] [Related]
18. [The new anticoagulants].
Nemets A; Lishner M; Lugassy G
Harefuah; 2011 May; 150(5):458-62, 490. PubMed ID: 21678643
[TBL] [Abstract][Full Text] [Related]
19. [New anticoagulants: dabigatran, rivaroxaban and apixaban].
Vargas Ruiz AG; Ramírez López AN; Medina Viramontes ME
Gac Med Mex; 2012; 148(3):257-64. PubMed ID: 22820359
[TBL] [Abstract][Full Text] [Related]
20. Clinical trials of direct thrombin and factor Xa inhibitors in atrial fibrillation.
Stewart RA
Curr Opin Cardiol; 2011 Jul; 26(4):294-9. PubMed ID: 21537165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
